DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Stifel Maintains Buy on Principia Biopharma, Raises Price Target to $76

Stifel maintains Principia Biopharma (NASDAQ:PRNB) with a Buy and raises the price target from $66 to $76.

Benzinga · 03/11/2020 12:43

Stifel maintains Principia Biopharma (NASDAQ:PRNB) with a Buy and raises the price target from $66 to $76.